Influence of performance status on the effectiveness of pembrolizumab monotherapy in first-line for advanced non-small-cell lung cancer: Results in a real-world population

  1. Galán, R.J.
  2. Prado-Mel, E.
  3. Pérez-Moreno, M.A.
  4. Caballano-Infantes, E.
  5. Moreno, S.F.

ISSN: 2079-7737

Year of publication: 2021

Volume: 10

Issue: 9

Type: Article

DOI: 10.3390/BIOLOGY10090890 GOOGLE SCHOLAR lock_openOpen access editor